Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,978.00p
   
  • Change Today:
    -5.00p
  • 52 Week High: 2,205.00
  • 52 Week Low: 1,722.00
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 219,722
  • Market Cap: £4,388.89m
  • RiskGrade: 125

Friday broker round-up

By Caoimhe Toman

Date: Friday 04 Sep 2020

LONDON (ShareCast) - (Sharecast News) - Imperial Brands: JP Morgan upgrades to overweight with a target price of 1,650.0p.



Blue Prism: Berenberg reiterates buy with a target price of 1,425.0p.

Pearson: Berenberg reiterates sell with a target price of 450.0p.

Gulf Keystone: Canaccord reiterates buy with a target price of 180.0p.

Smiths Group: JP Morgan reiterates overweight with a target price of 1,685.0p.

EnQuest: Barclays reiterates equal weight with a target price of 18.0p.

Hikma Pharmaceuticals: Barclays upgrades to overweight with a target price of 2,800.0p.

AngloAmerican: Deutsche Bank reiterates buy with a target price of 2,500.0p.

RPS Group: Liberum reiterates buy with a target price of 80.0p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,978.00p
Change Today -5.00p
% Change -0.25 %
52 Week High 2,205.00
52 Week Low 1,722.00
Volume 219,722
Shares Issued 221.89m
Market Cap £4,388.89m
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
50.93% below the market average50.93% below the market average50.93% below the market average50.93% below the market average50.93% below the market average
25.49% below the sector average25.49% below the sector average25.49% below the sector average25.49% below the sector average25.49% below the sector average
Price Trend
52.52% above the market average52.52% above the market average52.52% above the market average52.52% above the market average52.52% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average
Income
11.48% above the market average11.48% above the market average11.48% above the market average11.48% above the market average11.48% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
36.86% below the market average36.86% below the market average36.86% below the market average36.86% below the market average36.86% below the market average
23.53% below the sector average23.53% below the sector average23.53% below the sector average23.53% below the sector average23.53% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 1
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 21-Mar-24 10-Aug-23
Paid 03-May-24 15-Sep-23
Amount 47.00¢ 25.00¢

Trades for 17-May-2024

Time Volume / Share Price
16:35 116,534 @ 1,978.00p
16:35 238 @ 1,978.00p
16:35 97 @ 1,978.00p
16:35 88 @ 1,978.00p
16:35 328 @ 1,978.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page